The Belgian Food Safety Agency recently provided advice on the microbial and chemical safety of insects intended for human consumption.

On January 22, 2015, EFSA announced it would make it easier for external observers to attend open plenary meetings by increasing its scientific panels and Scientific Committee open plenary meetings to be held in Brussels.

During this webinar, Kirian Claeyé and Bart Junior Bollen guide you through the eagerly anticipated reform of the reimbursement procedures for medicines in Belgium.

In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs

The default legal position is that the UK will leave the EU automatically at 11pm on 29 March 2019 with no "deal" in place, unless something else is agreed.

On Thursday, FDA published the final guidance document, "Determining Whether to Submit an ANDA or a 505(b)(2) Application" that contains minor revisions ...

On June 18, the Food and Drug Administration (FDA) issued its final guidance document on added sugars labeling for honey, maple syrup, and other single-ingredient sugars and syrups; and certain cranberry products.

The European Medicines Agency (EMA) has committed early patient access to new medicines, particularly those that target an unmet medical need or are of major public health interest.

On 4 June, the Council of the European Union (Council) adopted its negotiation position on the proposals for a new regulation and directive that make up the so-called ‘pharma package'.

Following the change of mind that is taking place in many jurisdictions around the world, Belgium is gradually taking steps relating to the production and research into cannabis products for medicinal purposes.

Food law is extensively harmonized throughout the EU, but national law still has a role to play. In this short article, we look at two developments in Belgian food law that have taken place in 2023...

Under Article 4 of the Directive, a person injured by a defective product should prove the damage, the defect and the causal relationship between defect and damage.

Food company Mowi Poland successfully challenged the European Commission's new hygiene rules governing ‘stiffening'—a specialised fish processing technique—on the grounds...

On 4 June 2015, the Court of Justice of the European Union (the "ECJ") ruled on a request for a preliminary ruling from the German Supreme Court (Bundesgerichtshof) regarding the misleading labelling of foodstuffs...

The European Commission has authorised a new food health claim recognising the digestive health benefits of green kiwifruit. The claim—"Consumption of green kiwifruit contributes...

In an interim judgment of 5 May 2015, the Brussels Court of Appeal referred three questions for a preliminary ruling to the Court of Justice of the European Union.

On June 4, 2025, after nearly two years of intense debate and negotiation between the 27 EU Member States, the Council of the European Union adopted its position on the proposed overhaul of the EU general pharmaceutical legislative framework known as the new Pharma Package.

On 28 January 2015, in two separate decisions, the European Commission conditionally approved a complex transaction between pharmaceuticals producers GlaxoSmithKline (GSK) and Novartis.

Subject to a few exceptions, EU Member States should apply the national implementing measures of the TPD as from 20 May 2016.

Following the entry into application of the Clinical Trials Regulation (EU) 536/2014 (CTR) for all initial clinical trial applications on 31 January 2023, the European Medicines Agency...